Join today and have your say! It’s FREE!

Become a member today, It's free!

We will not release or resell your information to third parties without your permission.
Please Try Again
{{ error }}
By providing my email, I consent to receiving investment related electronic messages from Stockhouse.

or

Sign In

Please Try Again
{{ error }}
Password Hint : {{passwordHint}}
Forgot Password?

or

Please Try Again {{ error }}

Send my password

SUCCESS
An email was sent with password retrieval instructions. Please go to the link in the email message to retrieve your password.

Become a member today, It's free!

We will not release or resell your information to third parties without your permission.
Quote  |  Bullboard  |  News  |  Opinion  |  Profile  |  Peers  |  Filings  |  Financials  |  Options  |  Price History  |  Ratios  |  Ownership  |  Insiders  |  Valuation

Bullboard - Stock Discussion Forum TELESTA THERAPEUTICS INC T.TST

"Telesta Therapeutics Inc is a biopharmaceutical company. The Company is engaged in the research, development, manufacturing and commercialization of human health products and technologies."

TSX:TST - Post Discussion

TELESTA THERAPEUTICS INC > Who would sell at 18-19 cents?
View:
Post by RetailRube on Apr 30, 2014 10:56am

Who would sell at 18-19 cents?

Shareholders had the right to compel Bioniche to buy 100% of their shares at 23 cents by dissenting to the proposed sale of the Animal Health Business.  So anyone selling today at 18-19 cents in size is either lazy or knows something that is new-news since the Special Shareholder Meeting on April 14th.

Granted, to dissent, the shareholder would have to register their shares and then submit a written Dissent Notice.  That could have been presented at any time up to the start of the meeting, including handing it to the Chairman.  Then a few weeks later, the shareholder would have to submit a written Payment Demand to the company.  They are entitled to receive fair market value established as at the close of business prior to the meeting.  The close price the on Friday April 11th was 23 cents.

Bioniche reserved the right to cancel the sale if more than 10% of shares asked to be bought back.  That means the company was prepared to buy back up to 14 million shares.

So anyone selling today just likes to lose money.

One possible source of selling is the group of Animal Health employees who learned on April 16th (the first day the new guys took over) that they would not be offered jobs by the new owners.  Those people are now out of work and likely as angry as Zep.  They might be selling now.
Comment by robertjohny on Apr 30, 2014 10:59am
This post has been removed in accordance with Community Policy
The Market Update
{{currentVideo.title}} {{currentVideo.relativeTime}}
< Previous bulletin
Next bulletin >

At the Bell logo
A daily snapshot of everything
from market open to close.

{{currentVideo.companyName}}
{{currentVideo.intervieweeName}}{{currentVideo.intervieweeTitle}}
< Previous
Next >
Dealroom for high-potential pre-IPO opportunities